Search - tctmd.com

Displaying 621 - 640 of 879

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Urgent Transcatheter Aortic Valve Replacement for Severe Acute Aortic Regurgitation Following Open Mitral Valve Surgery

Presenter: Ashish Pershad, Roberto Spina, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Is Paravalvular Regurgitation After TAVR Still an Important Consideration in 2018?

Presenter: Philippe Pibarot

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #3: A Small (Undersized) Surgical Bioprosthesis

Presenter: Michael J. Reardon, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC

Presenter: Amar Krishnaswamy

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Transcaval TAVR Complicated by Double Wammy

Presenter: Ashish Pershad, Waleed Alharbi, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

Presenter: Brian K. Whisenant, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC

Presenter: Fabian Nietlispach

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Eberhard Grube, Tamim Nazif

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Presenter: George D. Dangas

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #1: A Poorly Visible Surgical Bioprosthesis

Presenter: Isaac George, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

An Unexpected Apparition - or - Old Valves Die Hard

Presenter: Ashish Pershad, Takehiro Yamashita, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Special Considerations for Transcatheter Therapies in Patients With Functional MR and TR (Access, Imaging, and Device Selection)

Presenter: Anthony N. DeMaria, Allan Schwartz, Scott Lim

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cedars-Sinai Medical Center (USA)

Presenter: Tarun Chakravarty

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Rare Cause of Stroke After TAVR: Foreign Body

Presenter: Ashish Pershad, Abhishek Bhagat, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Growing Conundrum: Coronary Access After TAVR Technical Tips and Tricks

Presenter: James B. Hermiller Jr

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Lessons Learned From Surgery for Functional MR and TR to Guide Transcatheter Therapies

Presenter: Anthony N. DeMaria, Allan Schwartz, David H. Adams

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Erasmus University (The Netherlands)

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

What a NEAR MISS! Aortic Sinus to RV Fistula Post-TAVR Treated With Percutaneous Closure - Be Careful When Postdilating!

Presenter: Ashish Pershad, William Merhi, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization)

Presenter: Torsten P. Vahl

June 21, 2018

Advertisement

Urgent Transcatheter Aortic Valve Replacement for Severe Acute Aortic Regurgitation Following Open Mitral Valve Surgery

Is Paravalvular Regurgitation After TAVR Still an Important Consideration in 2018?

Case #3: A Small (Undersized) Surgical Bioprosthesis

An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC

Transcaval TAVR Complicated by Double Wammy

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Case #1: A Poorly Visible Surgical Bioprosthesis

An Unexpected Apparition - or - Old Valves Die Hard

Special Considerations for Transcatheter Therapies in Patients With Functional MR and TR (Access, Imaging, and Device Selection)

Cedars-Sinai Medical Center (USA)

A Rare Cause of Stroke After TAVR: Foreign Body

A Growing Conundrum: Coronary Access After TAVR Technical Tips and Tricks

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Lessons Learned From Surgery for Functional MR and TR to Guide Transcatheter Therapies

Erasmus University (The Netherlands)

What a NEAR MISS! Aortic Sinus to RV Fistula Post-TAVR Treated With Percutaneous Closure - Be Careful When Postdilating!

Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content